A. Webb

发表

Genetic Variants Predict Optimal Timing of Radiotherapy to Reduce Side-effects in Breast Cancer Patients.

J. Chang-Claude, P. Seibold, C. West, 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).

REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer.

J. Chang-Claude, T. Vercauteren, A. Dunning, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National Cohort

J. Chang-Claude, A. Dunning, R. Stock, 2020, Frontiers in Oncology.

Development and Optimization of a Machine-Learning Prediction Model for Acute Desquamation After Breast Radiation Therapy in the Multicenter REQUITE Cohort

J. Chang-Claude, D. Soria, P. Seibold, 2022, Advances in radiation oncology.

Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort

Tim E. Ward, J. Chang-Claude, P. Seibold, 2022, EBioMedicine.

High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer

J. Chang-Claude, K. Haustermans, P. Seibold, 2022, Frontiers in Oncology.

The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study.

Tim E. Ward, J. Chang-Claude, P. Seibold, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study.

Tim E. Ward, J. Chang-Claude, P. Seibold, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Use of Angiotensin Converting Enzyme Inhibitors is Associated with Reduced Risk of Late Bladder Toxicity Following Radiotherapy for Prostate Cancer.

Tim E. Ward, J. Chang-Claude, E. Messing, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

A data science approach for early-stage prediction of Patient's susceptibility to acute side effects of advanced radiotherapy

Daniele Soria, Thierry J. Chaussalet, Barry S. Rosenstein, 2021, Comput. Biol. Medicine.

Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity

J. Chang-Claude, A. Dunning, R. Stock, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

External Validation of a Predictive Model for Acute Skin Radiation Toxicity in the REQUITE Breast Cohort

J. Chang-Claude, A. Dunning, P. Seibold, 2020, Frontiers in Oncology.

Requite: Validating Predictive Models and Biomarkers of Radiotherapy Toxicity to Reduce Side-Effects and Improve Quality-of-Life in Cancer Survivors

J. Chang-Claude, P. Seibold, D. Ruysscher, 2019, International Journal of Radiation Oncology*Biology*Physics.

From kilovoltage to genetically predicted personalised radiotherapy: a quest to reduce breast radiotherapy side effects

C. Talbot, P. Symonds, T. Rattay, 2023, Journal of Radiotherapy in Practice.

Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer.

J. Chang-Claude, C. Luccarini, P. Seibold, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study).

Tim E. Ward, J. Chang-Claude, A. Dunning, 2022, Lung Cancer.

(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer

Tim E. Ward, J. Chang-Claude, P. Seibold, 2023, International journal of cancer.

Contouring variation affects estimates of normal tissue complication probability for breast fibrosis after radiotherapy

Maria Carmen De Santis, P. Seibold, D. Ruysscher, 2023, Breast.

The REQUITE Project: Validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality of life in cancer survivors.

P. Lambin, D. Ruysscher, S. Gutiérrez‐Enríquez, 2016 .

OC-0647 Analysis of biomarkers for late radiotherapy toxicity in the REQUITE project

P. Lambin, J. Chang-Claude, P. Seibold, 2019, Radiotherapy and Oncology.

Genetic Variants Predict Optimal Timing of Radiotherapy to Reduce Side-effects in Breast Cancer Patients.

P. Seibold, D. Ruysscher, B. Rosenstein, 2019, Clinical oncology (Royal College of Radiologists (Great Britain)).